Detalles de la búsqueda
1.
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study.
Blood
; 135(8): 534-541, 2020 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31877211
2.
Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline.
Ann Hematol
; 98(10): 2329-2338, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31392461
3.
Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia.
Hematol Oncol
; 31(2): 103-9, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22815278
4.
Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation Sequencing.
Biomedicines
; 11(2)2023 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36830896
5.
BCR::ABL1 levels at first month after TKI discontinuation predict subsequent maintenance of treatment-free remission: A study from the "GRUPPO TRIVENETO LMC".
Cancer Med
; 12(3): 3180-3184, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36208021
6.
Making Treatment-Free Remission (TFR) Easier in Chronic Myeloid Leukemia: Fact-Checking and Practical Management Tools.
Target Oncol
; 16(6): 823-838, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34661826
7.
Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response.
Haematologica
; 100(8): e299-301, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25820333
8.
Combination of EUTOS score and 3-month BCR-ABL transcript level identifies a group of good-risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy.
Am J Hematol
; 90(7): E135-7, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25808917
9.
EUTOS score predicts early optimal response to imatinib according to the revised 2013 ELN recommendations.
Ann Hematol
; 93(1): 163-4, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24292539
10.
A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements.
Blood Cancer J
; 14(1): 53, 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38531834
11.
Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients.
Oncotarget
; 9(18): 14219-14227, 2018 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29581839
12.
The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery.
Exp Hematol
; 34(3): 389-96, 2006 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16543073
13.
The prognostic value of P-glycoprotein (ABCB) and breast cancer resistance protein (ABCG2) in adults with de novo acute myeloid leukemia with normal karyotype.
Haematologica
; 91(6): 825-8, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16704962
14.
Effect of amifostine on the cytotoxicity of daunorubicin and daunoxome in tumor and normal cells.
Cancer Chemother Pharmacol
; 57(4): 517-24, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16001170
15.
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome.
Oncotarget
; 7(48): 80083-80090, 2016 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-27579540
16.
EUTOS score predicts long-term outcome but not optimal response to imatinib in patients with chronic myeloid leukaemia.
Leuk Res
; 37(11): 1457-60, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23993428
17.
Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study.
Drugs Aging
; 30(8): 629-37, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23681399
18.
The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype.
Hematol Oncol
; 25(1): 38-43, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17200981
19.
Epstein-Barr virus reactivation in a patient treated with anti-thymocyte globulin for severe aplastic anemia.
Am J Hematol
; 81(5): 355-7, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16628717
20.
Complete remission induced by thalidomide in a case of angioimmunoblastic T-cell lymphoma refractory to autologous stem cell transplantation.
Leuk Lymphoma
; 49(9): 1836-8, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18661402